NICLOSAMIDE FOR COVID TREATMENT
07
Jun
NICLOSAMIDE FOR COVID TREATMENT Subject: Science & tech Context: Recently, the Council of Scientific and Industrial Research (CSIR) in collaboration with Laxai Life Sciences began the phase-II clinical trials of the Niclosamide drug for treatment of Covid-19. Concept: Niclosamide It is an orally bioavailable chlorinated salicylanilide, with anthelmintic and potential antineoplastic activity. It […]